Heterocyclic n-aryl carboxamides as cytokine inhibitors
CA 2518774 C · Owner: Hammach, Abdelhakim · Inventors: Kamhi, Victor Marc; Ralph, Mark Stephen; Qian, Kevin Chungeng
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Disclosed are compounds of formula (I) where Ar1 X, Y, Q, W, R3, R4, R5, R6 , and Ry are defined herein. The compounds of the invention inhibit production of cytokines involved in inflammatory processes and are thus useful for treating diseases and pathological conditions involving inflammation such as chronic inflammatory disease. Also disclosed are processes for preparing these compounds and pharmaceutical compositions comprising these compounds.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 2, 2004 and granted August 27, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended March 2, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 2, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.